Here, we compared serum pan-Ig, IgG, IgM and IgA antibodies on the same assay platform indicating that measurement of IgG antibodies against SARS-CoV-2 most effectively differentiated convalescent patient serum from pre-COVID-19 serum. This evidence concerns the gene CD79A and COVID-19.